|
Redasoft, Blue Stallion Sign Distribution Agreement for Visual Cloning Software in South Africa.
Redasoft, Blue Stallion Sign Distribution Agreement for Visual Cloning Software in South Africa.
Toronto, ON - March 19, 2003 - Redasoft, a global provider of drug discovery productivity enhancement software for the life science research community and Blue Stallion, the leader in asset management software for laboratories worldwide, today announced an agreement for the distribution of Redasofts desktop software product, Visual Cloning.
"South Africa is an exciting growth opportunity for biotechnology," said Danny Reda, Redasofts President and Chief Executive Officer. "Through aggressive government programs such as Biopad and the eGoli Bio incubator, South Africa is well positioned to actually commercialize much of their world-class biotechnology research and create successful innovative companies. We are therefore extremely pleased to partner with Blue Stallion in the South African market."
Redasoft Visual Cloning is an industry leading software suite that enables increased efficiency and productivity in drug discovery research. Key features of the software include exceptional graphics, extensive web integration, advanced restriction analysis, open reading frames search, primer design, a sequence viewer, subsequence search, and an intuitive user interface.
About Blue Stallion
Blue Stallion Technologies is based in Johannesburg, South Africa. Using more than a decade of experience, leading edge scientific and technical software products are identified internationally, and then distributed and supported locally. Their customer base includes government departments, large corporations and all the major universities in South Africa. Additional information about Blue Stallion can be found at http://www.bluestallion.co.za/"> http://www.bluestallion.co.za/.
About Redasoft
Based in Toronto, Canada, Redasoft is a global provider of drug
discovery productivity enhancement software for the life science
research community. Founded in 1997, Redasofts mission is to be an
enabling solutions provider of intuitive, easy to use integrating
software and services for drug discovery research. Redasoft's
software empowers life science researchers to visualize genetic
data, analyze biomolecules, and develop experiment strategies to
learn more about the fundamental building blocks of life. Additional
information about Redasoft can be found at
http://www.redasoft.com">http://www.redasoft.com.
Redasoft and the Redasoft logo are trademarks of Redasoft
Corporation. The names of actual companies and products mentioned
herein may be the trademarks of their respective owners.
Note to editors: If you are interested in viewing additional
information on Redasoft, please visit the Redasoft Web page at
http://www.redasoft.com/corporate">
http://www.redasoft.com/corporate/ on Redasoft's corporate
information pages.
Contact
Evan Carmichael, Redasoft, at ecarmichael@redasoft.com.
|